Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for Tandem Diabetes Care (TNDM) over the last 13 years, with Q3 2025 value amounting to $874.7 million.

  • Tandem Diabetes Care's Liabilities and Shareholders Equity fell 867.44% to $874.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.6 billion, marking a year-over-year decrease of 392.58%. This contributed to the annual value of $967.7 million for FY2024, which is 157.45% up from last year.
  • Latest data reveals that Tandem Diabetes Care reported Liabilities and Shareholders Equity of $874.7 million as of Q3 2025, which was down 867.44% from $875.7 million recorded in Q2 2025.
  • In the past 5 years, Tandem Diabetes Care's Liabilities and Shareholders Equity registered a high of $1.1 billion during Q4 2022, and its lowest value of $754.3 million during Q1 2021.
  • For the 5-year period, Tandem Diabetes Care's Liabilities and Shareholders Equity averaged around $933.0 million, with its median value being $941.0 million (2024).
  • Its Liabilities and Shareholders Equity has fluctuated over the past 5 years, first skyrocketed by 11969.52% in 2021, then tumbled by 1027.29% in 2023.
  • Over the past 5 years, Tandem Diabetes Care's Liabilities and Shareholders Equity (Quarter) stood at $905.1 million in 2021, then rose by 16.31% to $1.1 billion in 2022, then fell by 9.51% to $952.7 million in 2023, then rose by 1.57% to $967.7 million in 2024, then fell by 9.61% to $874.7 million in 2025.
  • Its Liabilities and Shareholders Equity was $874.7 million in Q3 2025, compared to $875.7 million in Q2 2025 and $922.1 million in Q1 2025.